39
3
7
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8863 |
VK-II-36
|
Others | Others |
VK-II-36 是 carvedilol 的类似物,能够在不阻断 β 受体的情况下抑制肌浆网钙释放。它能够抑制早期和延迟后去极化诱发的触发活动,可用于局灶性室性心律失常的研究。 | |||
T2613 |
Almorexant
阿莫伦特,ACT 078573 |
OX Receptor | GPCR/G Protein; Neuroscience |
Almorexant (ACT 078573) 是一种有效的竞争性食欲素 1 受体 (OX1)/食欲素 2 受体 (OX2) 双重拮抗剂,OX1 和 OX2 的 Ki 值分别为 1.3 和 0.17 nM。 | |||
T2134 |
Dorzolamide hydrochloride
MK507 hydrochloride,L671152 hydrochloride,MK-507 (L-671152) HCl,盐酸多佐胺,Dorzolamide HCl |
Carbonic Anhydrase | Metabolism |
Dorzolamide hydrochloride (MK507 hydrochloride) 是一种碳酸酐酶carbonic anhydrase II 抑制剂,能够抑制红细胞CA-II(IC50:0.18 nM) 和CA-I(IC50:600 nM) 。 | |||
T6155 |
Almorexant hydrochloride
ACT-078573 hydrochloride,Almorexant HCl |
OX Receptor | GPCR/G Protein; Neuroscience |
Almorexant hydrochloride (ACT-078573 hydrochloride) 是一种有效的竞争性食欲素 1 受体(OX1)/食欲素 2 受体 (OX2) 双重拮抗剂,OX1 和 OX2 的 Ki 值分别为 1.3 和 0.17 nM。 | |||
T67774 |
Compound CDy9
|
Carbonic Anhydrase | Metabolism |
Compound CDy9 是碳酸酐酶(CA)的高选择性抑制剂,对hCA II 的IC50值为0.18μM。 | |||
T36758 |
CAIX Inhibitor S4
S4 |
Carbonic Anhydrase | Metabolism |
CAIX Inhibitor S4 (S4) 是一种有效的碳酸酐酶 IX/XII 抑制剂,Ki 分别为 7 nM 和 2 nM。 CA II 和 CA I 的 Ki 分别为 546 和 5600 nM。 | |||
T61745 |
hCAI/II-IN-6
|
Carbonic Anhydrase | Metabolism |
hCAI/II-IN-6 是一种具有选择性和口服活性的human carbonic anhydrase(CA) 抑制剂。hCAI/II-IN-6对 hCA I,hCA II,hCA VII 和 hCA XII 有抑制作用,Ki 值分别为 220,4.9,6.5 和 >50000 nM。hCAI/II-IN-6 在体内显示抗惊厥活性。hCAI/II-IN-6 可以用于研究癫痫。 | |||
T67775 |
Enpp/Carbonic anhydrase-IN-1
|
PDE; Carbonic Anhydrase | Metabolism |
Enpp/Carbonic anhydrase-IN-1 (compound 1e) 是有效的 Enpp 和 carbonic anhydrase 抑制剂。Enpp/Carbonic anhydrase-IN-1抑制 NPP1、NPP2、NPP3、CA-II、CA-IX 的 IC50 值分别 1.36、1.35、3.00、0.88、1.02 µM。Enpp/Carbonic anhydrase-IN-1 选择性抑制癌细胞的增殖,对正常细胞毒性较低。 | |||
T5181 |
CA-5f
|
Apoptosis; Autophagy | Apoptosis; Autophagy |
CA-5f 是晚期巨自噬/自噬抑制剂,通过抑制自噬体-溶酶体融合起作用。它能够增加监控自噬的标记物 LC3B-II 和 SQSTM1 蛋白水平,促进 ROS 的产生,具有抗肿瘤活性。 | |||
T23782 |
Benzolamide
CL-11366,W 1803,CL 11366,CL11366,苯唑拉胺,W-1803 |
Carbonic Anhydrase | Metabolism |
Benzolamide (CL 11366) 是碳酸酐酶 (CA) 抑制剂,抑制hCA I(Ki:15 nM)、hCA II(Ki:9 nM)、EcoCAγ(Ki:94 nM)、VchCAγ(Ki:78 nM)、CAS3(Ki:54 nM)。它可用于研究青光眼和癫痫。 | |||
T6503 |
Fluorometholone Acetate
NSC 47438,Flarex,Eflone,氟米龙醋酸酯,Oxylone acetate |
Glucocorticoid Receptor; Carbonic Anhydrase | Endocrinology/Hormones; Metabolism |
Fluorometholone Acetate (Oxylone acetate) 是合成的糖皮质激素皮质类固醇及皮质类固醇酯。它有效抑制碳酸酐酶 (CA) 对 hCA-I(IC50:2.18 μM)和 hCA-II(IC50:17.5 μM)。它具有抗炎活性,可用于研究外部眼部炎症。 | |||
T0142 |
Brinzolamide
布林佐胺,AL-4862 |
Carbonic Anhydrase | Metabolism |
Brinzolamide (AL-4862) 是一种碳酸酐酶(carbonic anhydrase)II 抑制剂(IC50:3.19 nM)。 | |||
T0267 |
Zonisamide
AD 810,唑尼沙胺,CI 912 |
Calcium Channel; Sodium Channel; Carbonic Anhydrase | Membrane transporter/Ion channel; Metabolism |
Zonisamide (AD 810) 是锌酶碳酸酐酶 (carbonic anhydrase) 的有效抑制剂,对人类线粒体同工酶 hCA II 和 hCA V 作用的 Ki 值分别为 35.2 nM 和 20.6 nM。Zonisamide 具有抗癫痫活性,在癫痫、癫痫发作和帕金森病的研究中具有价值。 | |||
T16557 |
PNU-159682
|
Topoisomerase | DNA Damage/DNA Repair |
PNU-159682 是蒽环类新霉素的代谢产物,是一种 DNA 拓扑异构酶 II 抑制剂,具有出色的细胞毒性。 | |||
T73177 |
hCAII-IN-9
|
Carbonic Anhydrase | Metabolism |
hCAII-IN-9 是一种强效的碳酸酐酶抑制剂,对hCA II、hCA IX 和hCA XII 有抑制作用,IC50 分别为 1.18 μM 和 0.17 μM , and 2.99 μM 。hCAII-IN-9 没有血脑屏障透过性。 | |||
T0106 |
Methazolamide
L584601,醋甲唑胺,CL 8490 |
Carbonic Anhydrase | Metabolism |
Methazolamide (CL 8490) 是一种磺胺衍生物,用作碳酸酐酶 (carbonic anhydrase) 抑制剂,对人 carbonic anhydrase II 的 Ki=为 14 nM。它是降低眼压的药物,能够抑制由青光眼及其他眼病引起的眼压升高的作用。 | |||
T79753 |
hCAIX/XII-IN-8
|
Carbonic Anhydrase | Metabolism |
hCAIX/XII-IN-8(compound 3g)是一种对人类(碳酸酐酶)CA IX和XII高效的抑制剂,Ki值分别为8.5和6.7 nM。该化合物对与肿瘤相关的膜结合异构体hCA IX和XII表现出显著的抑制作用,且相对于胞内异构体hCA I和II具有较高的选择性。 | |||
T74978 | DPP IV/hCA II-IN-1 | ||
DPP IV/hCA II-IN-1 是一种有效的选择性二肽肽酶 IV (DPP IV) 和碳酸酐酶 (CA) 抑制剂,抑制 DPP IV 的 IC50值为 0.049 μM, 抑制 CA II、CA VB、CA VA、CA IX、CA I 和 CA IV 的 Ki 值分别为 0.0361、0.0428、0.0941、0.1328、0.2615 和 3.034 μM。 | |||
T72122 |
Carbonic anhydrase inhibitor 12
|
Carbonic Anhydrase | Metabolism |
碳酸酐酶抑制剂12是针对CA II具有高效抑制作用的化合物,其Kis值仅为1.72 nM,对CA I亦表现出有效抑制(Kis为271 nM)。此外,该化合物在多种肿瘤细胞系中显示出显著的抗癌活性。 | |||
T61292 | CAII-IN-1 | ||
CAII-IN-1 (compound 3n) is a thiosemicarbazide derivative that acts as a potent and selective inhibitor of carbonic anhydrase-II (CA-II), with an IC50 value of 10.3 μM for bovine CA-II. This compound (CAII-IN-1) finds utility in research pertaining to carbonic anhydrase-associated biological disorders [1]. | |||
T83137 |
ALP/Carbonic anhydrase-IN-1
|
Carbonic Anhydrase | Metabolism |
ALP/Carbonic anhydrase-IN-1(Compound 1e)为碳酸酐酶(CA)与碱性磷酸酶(ALP)的双效抑制剂。对CA-II、CA-IX、CA-XII和ALP具有显著抑制活性,其IC50值分别为0.44 µM、1.61 µM、0.51 µM和0.107 µM。 | |||
T63005 |
Carbonic anhydrase inhibitor 11
|
||
Carbonic anhydrase inhibitor 11 (compound VI) 是一种有效的、选择性碳酸酐酶抑制剂,能够作用于 CA II (Ki: 40 nM)、CA IX (Ki: 39 nM) 和 CA XII (Ki: 900 nM)。 | |||
T61340 | CAII-IN-3 | ||
CAII-IN-3 (compound 3h) is a thiosemicarbazone derivative known for its potent inhibition of carbonic anhydrase-II (CA-II). It exhibits an IC50 value of 13.4 μM [1]. | |||
T61974 | CAII-IN-2 | ||
CAII-IN-2 (compound 3g) 是一种硫代氨基脲衍生物。CAII-IN-2是一种有效的选择性碳酸酐酶-II (CA-II) 抑制剂,抑制牛 CA-II 的 IC50为 12.1 μM。CAII-IN-2 在碳酸酐酶相关生物疾病中具有研究价值。 | |||
T72840 |
hCAIX/XII-IN-6
|
||
hCAIX/XII-IN-6 是具有口服活性的碳酸酐酶(CA)抑制剂,能够抑制人体 CA 亚型 hCA I、II、IV、IX 及 XII,其 Ki 值分别为 6697 nM、2950 nM、4093 nM、4.1 nM 和 7.7 nM。适用于类风湿关节炎(RA)研究。 | |||
T64241 | Brinzolamide hydrochloride | ||
Brinzolamide (AL-4862) hydrochloride 是一种碳酸酐酶 II(carbonic anhydrase II)的选择性抑制剂 (IC50: 3.2 nM)。Brinzolamide hydrochloride 能够抑制睫状体 CA-II,减少房水分泌,进而降低眼压 (IOP)。Brinzolamide hydrochloride 能够用于研究青光眼疾病。 | |||
T63731 | Carbonic anhydrase inhibitor 9 | ||
Carbonic anhydrase inhibitor 9 是碳酸酐酶 (CA) 的有效抑制剂,能够作用于 hCA II (Ki: 56.4 nM) 和 IX (Ki: 56.9 nM),表现出抗增殖效果。 | |||
T60515 | CaMKIIα-IN-1 | ||
CaMKIIα-IN-1 (Compound 4d) 是一种具有口服活性的 Ca 2+/钙调素依赖性蛋白激酶 II α (CaMKIIα) 抑制剂。CaMKIIα-IN-1对 CaMKIIα WT hub 的 Kd 值为 219 nM。CaMKIIα-IN-1 表现出良好的代谢稳定性。 | |||
T63753 |
hCAIX-IN-3
|
||
hCAII-IN-3 (compound 7e) 是选择性的、有效的碳酸酐酶 (CA II/IX) 抑制剂,他们的 Kis 值分别为 124.2 和 30.5 nM。hCAII-IN-1 对癌症疾病表现出研究潜力。 | |||
T63752 | hCAII-IN-1 | ||
hCAII-IN-1 (compound 7f) 是选择性的、有效的碳酸酐酶 (CA II/IX) 抑制剂,他们的 Kis 值分别为 1.2 和 113.6 nM。hCAII-IN-1 对癌症疾病表现出研究潜力。 | |||
T61842 | Carbonic anhydrase inhibitor 14 | ||
Carbonic anhydrase inhibitor 14 (Compound 8b) is a potent CA inhibitor, exhibiting K i values of 1203, 99.7, 9.4, and 27.7 nM against hCA I, hCA II, hCA IX, and hCA XII, respectively. Additionally, it effectively inhibits CDK2 with an IC 50 of 20.3 μM. Furthermore, Carbonic anhydrase inhibitor 14 demonstrates significant antitumor activity [1]. | |||
T39255 |
β-Cyfluthrin
beta-Cyfluthrin,β-Cyfluthrin |
||
β-Cyfluthrin is a type II synthetic pyrethroid compound commonly utilized as an active ingredient in agricultural insecticide products. It exerts its insecticidal properties by acting as a neurotoxicant, primarily impacting the calcium concentration within nervous tissue. This effect is achieved through the inhibition of Ca 2+ ATPase, a crucial component involved in calcium transport. | |||
T60602 | hCAIX/XII-IN-5 | ||
hCAIX/XII-IN-5 (Coumarin 9a) 是一种碳酸酐酶 (CA) 抑制剂,具有出色的 hCA IX/XII 选择性,对 hCA I 和 hCA II 的Ki 值分别为 93.9 和 85.7 nM。hCAIX/XII-IN-5 对癌细胞具有抗增殖活性,可延迟细胞周期并诱导细胞凋亡。 | |||
T35713 | N-desethyl Brinzolamide (oxalate) | ||
N-desethyl Brinzolamide is an active metabolite of the carbonic anhydrase (CA) inhibitor brinzolamide .1It inhibits CAII and CAIV activities (IC50s = 1.28 and 128 nM, respectively). 1.Kim, C.-Y., Whittington, D.A., Chang, J.S., et al.Structural aspects of isozyme selectivity in the binding of inhibitors to carbonic anhydrases II and IVJ. Med. Chem.45(4)888-893(2002) | |||
T76021 | Myelin Basic Protein TFA | ||
Myelin Basic Protein (MHP4-14) TFA 是一种合成肽,包含髓鞘碱性蛋白的残基4-14,是一种非常有选择性的 PKC 底物 (Km=7 μM)。Myelin Basic Protein TFA 不被环腺苷酸依赖性蛋白激酶、酪蛋白激酶 I 和 II、Ca2+/钙调素依赖性蛋白激酶 II 或磷酸化酶激酶磷酸化,可常规用于测定粗组织提取物中低背景的蛋白激酶 C。 | |||
T37847 |
Zonisamide-13C2,15N
Zonisamide-13C2,15N |
||
Zonisamide-13C2,15N is intended for use as an internal standard for the quantification of zonisamide by GC- or LC-MS. Zonisamide is an antiepileptic agent.1 It selectively inhibits the repeated firing of sodium channels (IC50 = 2 μg/ml) in mouse embryo spinal cord neurons and inhibits spontaneous channel firing when used at concentrations greater than 10 μg/ml.2 In rat cerebral cortex neurons, zonisamide (1-1,000 μM) inhibits T-type calcium channels with a maximum reduction of 60% of the calcium... | |||
T79748 |
hCAIX/XII-IN-7
|
Carbonic Anhydrase | Metabolism |
hCAIX/XII-IN-7(compound 3e)为高效的hCA IX与XII抑制剂,对hCA I、II、IX与XII的Ki值分别为3.2 nM、9.2 nM、503.7 nM及59 nM,显示其在缺氧肿瘤研究中的应用潜力。 | |||
T23567 |
Zonisamide sodium
|
Others | Others |
Zonisamide sodium is a 1,2 benzisoxazole derivative. It is the first agent of this chemical class to be developed as an antiepileptic drug. | |||
T78705 |
COX-2-IN-30
|
COX | Immunology/Inflammation; Neuroscience |
COX-2-IN-30 是苯磺酰胺衍生的口服活性 COX/5-LOX 双重抑制剂,其 IC50 值为 COX 同源物为 49 nM、5-LOX 同源物为 10.4 μM。此化合物还能纳摩尔级别 Ki 值抑制 hCA IX 与 hCA XII 亚型。COX-2-IN-30 具备镇痛、抗炎、致溃疡作用,不引发急性胃部反应。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3826 |
Polygalasaponin F
异牡荆苷,瓜子金皂苷己 |
NF-κB; TLR; Akt; PI3K | Cytoskeletal Signaling; Immunology/Inflammation; NF-κB; PI3K/Akt/mTOR signaling |
Polygalasaponin F 是从瓜子金中提取的齐墩果烷型三萜皂苷,可通过调节TLR4-PI3K/AKT-NF-kB 信号通路减少神经炎症细胞因子的分泌,能降低炎性细胞因子肿瘤坏死因子 α 的释放。 | |||
T75670 |
Lacto-N-fucopentaose II
|
||
Lacto-N-fucopentaose II (LNFP II)作为人Lewis血型决定因子的半抗原,其单唾液神经节苷/糖脂以及唾液酰衍生物CA 19-9,都是胆胰恶性肿瘤中的分子肿瘤标记物(TM)。 | |||
T82692 |
Comosone II
|
||
Comosone II (化合物4),一种从姜黄(Curcuma zedoaria)分离的化合物,展现中度抗增殖活性。对于Ca Ski癌细胞,其IC50值为76 μg/mL,显示其对癌细胞生长的抑制作用。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01735 |
Carbonic Anhydrase 2 Protein, Human, Recombinant (His)
HEL-S-282,CA-II,HEL-76,CAII |
Human | E. coli |
Carbonic Anhydrase 2 Protein, Human, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 30 kDa and the accession number is P00918. | |||
TMPH-03259 |
Carbonic Anhydrase 2 Protein, Rat, Recombinant (His)
CA-II,Carbonate dehydratase I... |
Rat | E. coli |
Essential for bone resorption and osteoclast differentiation. Reversible hydration of carbon dioxide. Contributes to intracellular pH regulation in the duodenal upper villous epithelium during proton-coupled peptide absorption. Stimulates the chloride-bicarbonate exchange activity of SLC26A6. Carbonic Anhydrase 2 Protein, Rat, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 31.7 kDa and the accession number is P27139. | |||
TMPJ-00701 |
Carbonic Anhydrase 11 Protein, Human, Recombinant (His)
Carbonic Anhydrase-Related Protein 2,CARP ... |
Human | HEK293 Cells |
Carbonic Anhydrase-Related Protein 11 (CA11) is a secreted protein member of the α-carbonic anhydrase family. Carbonic Anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. CA11 is expressed abundantly in the brain with moder... | |||
TMPY-01926 |
S100A10 Protein, Human, Recombinant (His)
ANX2L,S100 calcium binding protein A10,p10,CLP11,MG... |
Human | E. coli |
S100 protein is a family of low molecular weight protein found in vertebrates characterized by two EF-hand calcium-binding motifs. There are at least 21 different S100 proteins, and the name is derived from the fact that the protein is 100% soluble in ammonium sulfate at neutral pH. Most S100 proteins are disulfide-linked homodimer, and is normally present in cells derived from the neural crest, chondrocytes, macrophages, dendritic cells, etc. S1 proteins have been implicated in a variety of int... | |||
TMPY-01734 |
CA13 Protein, Human, Recombinant (His)
carbonic anhydrase XIII,FLJ37995,CA |
Human | E. coli |
The carbonic anhydrases (or carbonate dehydratases) are classified as metalloenzyme for its zinc ion prosthetic group and form a family of enzymes that catalyze the rapid interconversion of carbon dioxide and water to bicarbonate and protons, a reversible reaction that takes part in maintaining acid-base balance in blood and other tissues. The carbonic anhydrasekl (CA) family consists of at least 11 enzymatically active members and a few inactive homologous proteins. The CAXIII is a member of th... | |||
TMPY-02135 |
S100A16 Protein, Human, Recombinant
S100F,DT1P1A7,S100 calcium binding protein A16,MGC1... |
Human | E. coli |
S100A16 is a member of S100 protein superfamily that carries calcium-binding EF-hand motifs. S100 proteins are cell- and tissue-specific and are involved in many intra- and extracellular processes through interacting with specific target proteins. S100A16 expression was found to be astrocyte-specific. The S100A16 protein was found to accumulate within nucleoli and to translocate to the cytoplasm in response to Ca(2+) stimulation. The homodimeric structure of human S100A16 in the apo state has be... | |||
TMPY-04408 |
CAMKII beta/CAMK2B Protein, Human, Recombinant (His & GST)
calcium/calmodulin-dependent protein kinas... |
Human | Baculovirus Insect Cells |
Calcium/calmodulin-dependent protein kinase II beta (CAMK2B) is a member of the serine/threonine protein kinase family and to the Ca(2+)/calmodulin-dependent protein kinase subfamily. CaMKII is an important player in prostate cancer cells ability to escape apoptosis under androgen ablation and facilitate the progression of prostate cancer cells to an androgen independent state. As a multifunctional protein kinase, the loss of activity may play a critical role in initiating the changes leading to... |